Put Options

11 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$78.93 - $95.84 $8.55 Million - $10.4 Million
108,300 New
108,300 $9.73 Million
Q1 2022

May 17, 2022

SELL
$23.7 - $41.39 $495,330 - $865,051
-20,900 Reduced 40.9%
30,200 $1.25 Million
Q4 2021

Feb 15, 2022

SELL
$30.7 - $43.36 $2.27 Million - $3.2 Million
-73,800 Reduced 59.09%
51,100 $1.93 Million
Q3 2021

Nov 16, 2021

SELL
$19.91 - $68.26 $3.06 Million - $10.5 Million
-153,600 Reduced 55.15%
124,900 $4.12 Million
Q2 2021

Aug 16, 2021

SELL
$50.63 - $73.5 $4.3 Million - $6.25 Million
-85,000 Reduced 23.38%
278,500 $18.8 Million
Q1 2021

May 18, 2021

BUY
$55.91 - $81.44 $9.55 Million - $13.9 Million
170,800 Added 88.64%
363,500 $20.6 Million
Q4 2020

Feb 17, 2021

SELL
$66.31 - $86.52 $10.2 Million - $13.3 Million
-153,300 Reduced 44.31%
192,700 $15.7 Million
Q3 2020

Nov 17, 2020

BUY
$68.34 - $85.84 $205,020 - $257,520
3,000 Added 0.87%
346,000 $24.7 Million
Q2 2020

Aug 17, 2020

BUY
$49.87 - $98.69 $15.1 Million - $29.9 Million
303,100 Added 759.65%
343,000 $28.2 Million
Q1 2020

May 15, 2020

BUY
$41.2 - $101.31 $766,320 - $1.88 Million
18,600 Added 87.32%
39,900 $2.35 Million
Q4 2019

Feb 14, 2020

BUY
$16.71 - $106.24 $355,923 - $2.26 Million
21,300 New
21,300 $2.2 Million

Others Institutions Holding AXSM

About Axsome Therapeutics, Inc.


  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $4.18B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.